Life Sciences Tools and Services
Company Overview of U-Protein Express B.V.
U-Protein Express B.V. operates as a contract research organization that produces and markets recombinant proteins and antibodies for research and pre-clinical applications in Europe and internationally. The company’s product portfolio consists of antibodies, complement proteins, cytokines, enzymes, haematology, hormones, oncology, receptors, and others. It also offers proteins purification, recombinant antibody development and production, and monoclonal antibody generation services. U-Protein Express B.V. was incorporated in 2007 and is based in Utrecht, the Netherlands. As of August 22, 2017, U-Protein Express B.V. operates as a subsidiary of ImmunoPrecise Antibodies Ltd.
Utrecht Science Park
Utrecht, 3584 CM
Founded in 2007
31 30 253 7903
Key Executives for U-Protein Express B.V.
U-Protein Express B.V. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Applikon Biotechnology B.V.||Europe|
|Batavia Biosciences B.V.||Europe|
|Brain Technology Institute||Europe|
Recent Private Companies Transactions
July 4, 2017
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact U-Protein Express B.V., please visit www.u-proteinexpress.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.